Verona Pharma Cash Flow | StatInvestor

Health Care & Life Sciences » Biotechnology | Verona Pharma PLC

Verona Pharma PLC | Cash Flow

No data

About Verona Pharma

View Profile

Address	3 More London Riverside London Greater London SE1 2RE United Kingdom
Employees	-
Website	http://veronapharma.com
Updated	07/08/2019
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases. Verona Pharma's product include, RPL554, is a dual inhibitor of the enzymes phosphodiesterase 3 and 4 that acts as both a bronchodilator and an anti-inflammatory agent in a single compound. Verona Pharma is developing RPL554 for the treatment of chronic obstructive pulmonary disease (COPD), cystic fibrosis, and potentially asthma.